Kienlen-Campard P - Search Results

1

A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.

González de Aguilar JL, Gordon JW, René F, Lutz-Bucher B, Kienlen-Campard P, Loeffler JP. González de Aguilar JL, et al. Eur J Neurosci. 1999 Dec;11(12):4179-87. doi: 10.1046/j.1460-9568.1999.00840.x. Eur J Neurosci. 1999. PMID: 10594643

2

Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway.

Boutillier AL, Kienlen-Campard P, Loeffler JP. Boutillier AL, et al. Eur J Neurosci. 1999 Feb;11(2):441-8. doi: 10.1046/j.1460-9568.1999.00451.x. Eur J Neurosci. 1999. PMID: 10051745

3

GABAB receptors negatively regulate transcription in cerebellar granular neurons through cyclic AMP responsive element binding protein-dependent mechanisms.

Barthel F, Kienlen Campard P, Demeneix BA, Feltz P, Loeffler JP. Barthel F, et al. Neuroscience. 1996 Jan;70(2):417-27. doi: 10.1016/0306-4522(95)00380-0. Neuroscience. 1996. PMID: 8848150

4

Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.

Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pévet P. Simonneaux V, et al. Neuroscience. 1998 Aug;85(3):887-96. doi: 10.1016/s0306-4522(97)00668-4. Neuroscience. 1998. PMID: 9639281

5

PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway.

Kienlen Campard P, Crochemore C, René F, Monnier D, Koch B, Loeffler JP. Kienlen Campard P, et al. DNA Cell Biol. 1997 Mar;16(3):323-33. doi: 10.1089/dna.1997.16.323. DNA Cell Biol. 1997. PMID: 9115641

6

Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.

Muller A, Lutz-Bucher B, Kienlen-Campard P, Koch B, Loeffler JP. Muller A, et al. J Neurochem. 1998 Apr;70(4):1431-40. doi: 10.1046/j.1471-4159.1998.70041431.x. J Neurochem. 1998. PMID: 9523559 Free article.

7

APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation.

Stanga S, Zanou N, Audouard E, Tasiaux B, Contino S, Vandermeulen G, René F, Loeffler JP, Clotman F, Gailly P, Dewachter I, Octave JN, Kienlen-Campard P. Stanga S, et al. FASEB J. 2016 May;30(5):1696-711. doi: 10.1096/fj.15-278739. Epub 2015 Dec 30. FASEB J. 2016. PMID: 26718890

8

Correlation between beta-amyloid peptide production and human APP-induced neuronal death.

Kienlen-Campard P, Octave JN. Kienlen-Campard P, et al. Peptides. 2002 Jul;23(7):1199-204. doi: 10.1016/s0196-9781(02)00055-4. Peptides. 2002. PMID: 12128077

9

Epigenetic control of aquaporin 1 expression by the amyloid precursor protein.

Huysseune S, Kienlen-Campard P, Hébert S, Tasiaux B, Leroy K, Devuyst O, Brion JP, De Strooper B, Octave JN. Huysseune S, et al. FASEB J. 2009 Dec;23(12):4158-67. doi: 10.1096/fj.09-140012. Epub 2009 Aug 17. FASEB J. 2009. PMID: 19687153

10

Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.

Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, Haylani LE, Couturier J, Schakman O, Gailly P, Pierrot N, Kienlen-Campard P, Octave JN, Dewachter I. Stancu IC, et al. FASEB J. 2014 Jun;28(6):2620-31. doi: 10.1096/fj.13-246702. Epub 2014 Mar 6. FASEB J. 2014. PMID: 24604080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters